Filter
857
Text search:
pharmaceutical
regulations
Featured
Recommendations
70
New Publications
238
Language
Document type
No document type
425
Studies & Reports
168
Guidelines
141
Manuals
46
Strategic & Response Plan
45
Training Material
11
Fact sheets
10
Situation Updates
6
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Kenya
48
Global
28
India
26
Western and Central Europe
26
Nigeria
24
South Africa
23
Sierra Leone
22
Ethiopia
21
Uganda
19
Liberia
18
Ghana
18
Nepal
18
Tanzania
17
Rwanda
17
Zambia
13
Eastern Europe
13
Africa
12
Philippines
11
Indonesia
11
Bangladesh
10
Lesotho
10
Zimbabwe
9
Namibia
9
Myanmar / Burma
9
Malawi
8
Ukraine
7
South–East Asia Region
7
Latin America and the Carribbean
7
Cambodia
6
Eswatini/ Swaziland
6
West and Central Africa
6
Senegal
5
Thailand
5
Botswana
5
Eastern Europe and Central Asia
5
Cameroon
4
Syria
4
East and Southern Africa
4
Western Pacific Region
4
Burkina Faso
3
Haiti
3
Pakistan
3
Mozambique
3
Brazil
3
Laos
3
Russia
3
Guinea
2
Congo, Democratic Republic of
2
Mali
2
China
2
Sudan
2
North Macedonia
2
Middle East and North Africa
2
Asia
2
Fiji
2
Tajikistan
2
Kyrgyzstan
2
Vietnam
2
Somalia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Germany
1
Chad
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Peru
1
Serbia
1
El Salvador
1
Angola
1
Chile
1
Albania
1
Armenia
1
Canada
1
Timor Leste/ East Timor
1
Lithuania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
388
Clinical Guidelines
35
Key Resources
31
Public Health
29
Pharmacy & Technologies
23
Women & Child Health
13
Capacity Building
6
Toolboxes
AMR
137
Pharmacy
91
COVID-19
73
Rapid Response
35
Mental Health
35
TB
30
HIV
29
Planetary Health
18
Caregiver
17
Ebola
14
Global Health Education
12
Health Financing Toolbox
11
Conflict
10
NTDs
8
NCDs
8
Specific Hazards
6
Disability
5
Polio
2
Natural Hazards
2
Zika
2
Cholera
1
Refugee
1
Health Financing
1
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting
...
The thirty-seventh meeting of the Programme, Budget and Administration Committee was held in Geneva from 25 to 27 January 2023 and chaired by Ms Aishath Rishmee (Maldives). The Committee adopted its agenda and agreed its programme of work. In his opening remarks, the Director-General emphasized the
...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc
...
This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the key information needed for advising their Member States in response to questions raised on human health due to influenza outbreaks or detections in
...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy
...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de
...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline
...
The Disaster Recovery Framework (DRF) Guide for the Health Sector provides guidance on how to implement a comprehensive, integrated, and structured approach to disaster recovery. Its overarching goal is to minimize the impact of the disaster on communities and help countries to recover quickly and e
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti
...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging
...
